1-2 of 2
Hiroshi Ishida
Close
Save search
Sort by
Journal Articles

Anti–leukemia Activity of a Novel KIT Selective Inhibitor KI–328.

Free
Akane Tsujimura, MD, Yukimasa Shiotsu, PhD, Hitoshi Kiyoi, MD, Ph.D., Yuichi Ishikawa, MD, PhD, Hiroshi Ishida, Tsutomu Toki, PhD, Etsuro Ito, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4146.
https://doi.org/10.1182/blood.V114.22.4146.4146
Published: 2009
Journal Articles

Selective FLT3 Inhibitor FI-700 Neutralizes Mcl-1 and Enhances p53-Mediated Apoptosis in Acute Myeloid Leukemia (AML) Cells with Activating Mutations of FLT3 Via Mcl-1/Noxa Axis.

Free
Kensuke Kojima, MD, PhD, Marina Konopleva, MD, PhD, Twee Tsao, Michael Andreeff, MD, PhD, Hiroshi Ishida, Yukimasa Shiotsu, PhD, Linhua Jin, PhD, Yoko Tabe, MD, PhD, Hideki Nakakuma, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2597.
https://doi.org/10.1182/blood.V114.22.2597.2597
Published: 2009